Merck Schering Plough Vytorin Settlement
AP News 2009-08-05 13:34:10
FILE - In this 2004 file photo provided by Schering-Plough Corp., the cholesterol-lowering drug Vytorin, the product of a joint venture between pharmaceutical companies Merck & Co., and Schering-Plough Corp., is shown. Drug developers Merck & Co. and Schering-Plough Corp. said Wednesday, Aug. 5, 2009, they will pay $41.5 million to settle a series of lawsuits claiming they delayed key study results on their cholesterol drug Vytorin because the data was unfavorable. (AP Photo/Schering-Plough Corp., file)
Copyright 2009 AP News
